1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …

AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Abstract Background The PRAGUE-17 (Left Atrial Appendage Closure vs Novel
Anticoagulation Agents in Atrial Fibrillation) trial demonstrated that left atrial appendage …

Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Background Data on the impact of residual peri-device leak after left atrial appendage
occlusion (LAAO) are limited. Objectives The goal of this study was to explore the …

Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial
fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of …

Objectives This study sought to investigate clinical outcomes associated with left atrial
appendage occlusion (LAAO) versus direct oral anticoagulants (DOACs) in patients with …

Background Pivotal trials of percutaneous left atrial appendage occlusion (LAAO) used
specific postprocedure treatment protocols. Objectives This study sought to evaluate …

Introduction Stroke is one of the leading causes of mortality and morbidity globally. Atrial
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …